Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients

Abstract Autologous stem cell transplant (aHSCT) is associated with improved survival for multiple myeloma (MM) patients but may be associated with second primary malignancy (SPM) development. Using the California Cancer Registry linked to statewide hospitalization data, we determined the cumulative...

Full description

Bibliographic Details
Main Authors: A. S. Rosenberg, A. Brunson, J. Tuscano, B. A. Jonas, R. Hoeg, T. Wun, T. H. M. Keegan
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-020-00400-4